Labelling Requirements for Medical Devices under NT 37 Article 7

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The minimum labelling requirements for devices in Guatemala are set out in Article 7 of NT 37 Versión 5-2016: 10 items for the secondary packaging (product name, instructions for use and warnings, quantity or content, batch number, sanitary registration number, manufacturer name with manufacturing site and country, expiry date, the word “sterile”, dimensions, storage temperature) and 6 items for the primary packaging (product name, batch number, expiry date, sanitary registration number, the word “sterile”, dimensions). The last 4 items of the secondary list are marked as applicable when relevant. Supplementary information may be carried on a supplementary label or in the package insert, but it must be truthful, verifiable and not misleading to the consumer. Reading Article 7 as a dual checklist — one list per packaging level — is the simplest way to keep labelling design aligned with the standard from the first artwork draft onward.

  • The secondary packaging list contains ten items under Articles 7.1.1 to 7.1.10.
  • The primary packaging list contains six items under Articles 7.2.1 to 7.2.6, applying where secondary packaging exists.
  • The last four items of the secondary list — sterile marking, dimensions and storage temperature among them — are conditional.
  • For imported products, the instructions for use and warnings must be in Spanish.
  • The sanitary registration number appears at both packaging levels.
  • Supplementary information must be truthful, verifiable and non-misleading.

2. Legal basis

The table below reproduces the item lists of Article 7 by packaging level, together with the note that governs supplementary information. It is the reference table against which artwork should be checked before any mock-up is submitted under Article 5.1.10.

Packaging levelItem no.ContentClause
Secondary packaging1Product name (brand or generic name, as applicable)Article 7.1.1
Secondary packaging2Instructions for use and warnings; for imported products this information must be in SpanishArticle 7.1.2
Secondary packaging3Quantity or contentArticle 7.1.3
Secondary packaging4Batch numberArticle 7.1.4
Secondary packaging5Sanitary registration numberArticle 7.1.5
Secondary packaging6Manufacturer name, manufacturing site and country of manufactureArticle 7.1.6
Secondary packaging7Expiry dateArticle 7.1.7
Secondary packaging8The word “Estéril” (when applicable)Article 7.1.8
Secondary packaging9Dimensions (when applicable)Article 7.1.9
Secondary packaging10Storage temperature (when applicable)Article 7.1.10
Primary packaging1–6Product name, batch number, expiry date, sanitary registration number, the word “Estéril” (when applicable), dimensions (when applicable)Articles 7.2.1–7.2.6
Supplementary informationNoteInformation on supplementary labels or package inserts must be truthful and verifiable, and must not mislead or confuse the consumerArticle 7 NOTA

3. Expert insights

Insight one: the sanitary registration number appears at both packaging levels. Article 7.1.5 and Article 7.2.4 both require the “Número de inscripción sanitaria”. This means the registration number is not confined to the outer carton; it penetrates to the smallest sale unit. During the mock-up stage, before the registration has been granted, a space for the number must be reserved in the artwork, because obtaining the certificate afterwards and then remaking the packaging would require a change procedure under Article 6.11. Planning for the number from the first draft is therefore a scheduling protection, not a cosmetic detail.

Insight two: the Spanish-language requirement is selective, and it lands on the most critical item. Article 7.1.2 requires Spanish only for instructions for use and warnings on imported products; the remaining items carry no language stipulation. The placement is precise — the information directly tied to user safety must be localised. Companies that translate the entire label or translate nothing at all match neither reading of the clause. The practical rule is to anchor the Spanish obligation on the use-and-warnings item and treat the rest of the label as a design and market decision rather than a compliance mandate.

Insight three: the six primary-packaging items presuppose the existence of secondary packaging. The heading of Article 7.2 reads “Empaque primario (cuando exista empaque secundario)” — the primary packaging provisions apply only where secondary packaging exists. A product sold in a single pack, without a secondary level, is governed by Article 7.1 instead. This point is frequently overlooked in artwork reviews: applying the six-item primary list to a single-pack product, or failing to apply it where secondary packaging does exist, both produce misalignment with the standard’s actual structure.

Insight four: the three constraints on supplementary information are substantive. The note to Article 7 requires supplementary information to be “veraz, comprobable y no debe inducir a error o confusión del consumidor” — truthful, verifiable and not leading to error or confusion for the consumer. This draws a red line for promotional wording: indications and performance claims that exceed the registered scope fall foul of the note. Marketing teams should treat the note as a pre-clearance filter for every supplementary label and insert, because a claim that cannot be substantiated against the registration file is a compliance defect by definition.

4. Practical recommendations

  • Run a dual self-check against the ten items of Article 7.1 and the six items of Article 7.2, verifying each point in turn.
  • Ensure the instructions-for-use-and-warnings item is in Spanish for imported products, and localise the remaining items according to actual need.
  • Reserve a position for the sanitary registration number during artwork design, avoiding remake and change procedures after certification.
  • For products without secondary packaging, apply Article 7.1 and do not borrow the Article 7.2 list.
  • Pre-clear all supplementary label and insert content against the three tests: truthful, verifiable and not misleading.

5. Verification checklist

  • □ The ten items of secondary packaging have been checked one by one
  • □ The six items of primary packaging have been checked one by one, where secondary packaging exists
  • □ Instructions for use and warnings are in Spanish for imported products
  • □ A position for the sanitary registration number has been reserved at both packaging levels
  • □ The single-pack case has been handled under Article 7.1
  • □ Supplementary information has been pre-cleared against the three constraints

Regulatory information verified as of October 29, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail